Adrenaline, Noradrenaline and Dopamine Level Estimation in Depression : Does it Help?

BACKGROUND Abnormalities of catecholaminergic function have been hypothesised in causation of depressive illness. Electroconvulsive therapy (ECT) is postulated to have noradrenergic mechanism of action. We studied the clinical utility of estimating catecholamines level changes after ECT. METHODS Plasma adrenaline, noradrenaline and dopamine in healthy controls and depressed patients were estimated by high performance liquid chromatography with electrochemical detection method before and after ECT. RESULT Mean ± standard deviation of plasma adrenaline, noradrenaline and dopamine in controls was 36.7 ± 13.2, 209.3 ± 76, 21.8 ± 9.5 ng/L respectively, while in depressed patients before and after ECT it was found to be 32.5 ± 12.0, 419.3 ± 167.7, 22.1 ± 16.0ng/ L and 37.2 ± 19.6, 386.1 ± 168.4, 22.3 ± 15.5ng/L respectively. Correlation of adrenaline, noradrenaline and dopamine concentration with scores of Beck Depression Inventory, Suicidal Ideation Scale and Melancholia Inventory was positive but statistically not significant and poor. Based on the cut off values of noradrenaline, only 62% cases could be categorized as abnormal, which after ECT reduced to 50%, whereas post ECT psychiatric ratings was normal in about 78% cases. CONCLUSION There is no clinical significance of estimating adrenaline, noradrenaline and dopamine in depressed patients.

[1]  H. Shannon,et al.  Effects of Electroconvulsive Therapy on Peripheral Adrenoceptors, Plasma, Noradrenaline, MHPG and Cortisol in Depressed Patients , 1996, British Journal of Psychiatry.

[2]  T. Toyo’oka,et al.  Development of a 6-hydroxychroman-based derivatization reagent: application to the analysis of 5-hydroxytryptamine and catecholamines by using high-performance liquid chromatography with electrochemical detection. , 2008, Biomedical chromatography : BMC.

[3]  C. Kelly,et al.  Plasma noradrenaline response to a cognitive stressor in subtypes of depressive illness , 2000, Human psychopharmacology.

[4]  J. Queiroz,et al.  The effect of temperature on the analysis of metanephrine for catechol-O-methyltransferase activity assay by HPLC with electrochemical detection. , 2006, Biomedical chromatography : BMC.

[5]  D. Doerge,et al.  Quantification of rat brain neurotransmitters and metabolites using liquid chromatography/electrospray tandem mass spectrometry and comparison with liquid chromatography/electrochemical detection. , 2007, Rapid communications in mass spectrometry : RCM.

[6]  Jürgen Westermann,et al.  Simple, rapid and sensitive determination of epinephrine and norepinephrine in urine and plasma by non-competitive enzyme immunoassay, compared with HPLC method. , 2002, Clinical laboratory.

[7]  J. Halter,et al.  The effects of age on the plasma catecholamine response to mental stress in man. , 1982, The Journal of clinical endocrinology and metabolism.

[8]  M. Candito,et al.  Diagnostic biochimique du phéochromocytome et du neuroblastome , 2002 .

[9]  S. Cooper,et al.  Adrenergic Receptors in Depression , 1985, British Journal of Psychiatry.

[10]  A. J. Man in 't Veld,et al.  Optimal collection and storage conditions for catecholamine measurements in human plasma and urine. , 1993, Clinical chemistry.

[11]  S. Grover,et al.  Theories on Mechanism of Action of Electroconvulsive Therapy , 2005 .

[12]  D. Murphy,et al.  High plasma norepinephrine levels in patients with major affective disorder. , 1982, The American journal of psychiatry.

[13]  Robert T Peaston,et al.  Measurement of catecholamines and their metabolites , 2004, Annals of clinical biochemistry.

[14]  D. Murphy,et al.  Extreme elevations in plasma norepinephrine associated with decreased alpha-adrenergic responsiveness in major depressive disorder: two case reports. , 1983, Journal of clinical psychopharmacology.

[15]  M. Tsunoda Recent advances in methods for the analysis of catecholamines and their metabolites , 2006, Analytical and bioanalytical chemistry.

[16]  High plasma norepinephrine levels in patients with major affective disorder. , 1983, The American journal of psychiatry.

[17]  Y. Hishikawa,et al.  Single and repeated electroconvulsive shocks activate dopaminergic and 5-hydroxytryptaminergic neurotransmission in the frontal cortex of rats , 1998, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[18]  M. Candito,et al.  [Biochemical diagnosis of pheochromocytoma and neuroblastomas]. , 2002, Annales de biologie clinique.

[19]  J. Mann Neurobiological Correlates of the Antidepressant Action of Electroconvulsive Therapy , 1998, The journal of ECT.

[20]  S. Cooper,et al.  Plasma noradrenaline response to electroconvulsive therapy in depressive illness , 1997, British Journal of Psychiatry.